GB1354451A - Halogen-substituted phenyl-alkylamines and their derivatives - Google Patents

Halogen-substituted phenyl-alkylamines and their derivatives

Info

Publication number
GB1354451A
GB1354451A GB1244371A GB1244371A GB1354451A GB 1354451 A GB1354451 A GB 1354451A GB 1244371 A GB1244371 A GB 1244371A GB 1244371 A GB1244371 A GB 1244371A GB 1354451 A GB1354451 A GB 1354451A
Authority
GB
United Kingdom
Prior art keywords
group
carbon atoms
halogen
derivatives
hydroxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1244371A
Inventor
K Schromm
E-O Renth
A Mentrup
R Reichl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Original Assignee
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG, Boehringer Ingelheim GmbH filed Critical CH Boehringer Sohn AG and Co KG
Publication of GB1354451A publication Critical patent/GB1354451A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/32Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by introduction of halogenated alkyl groups into ring compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/08Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms
    • C07C205/09Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/562Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
    • C07C45/565Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom by reaction with hexamethylene-tetramine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/55Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64Acyl halides
    • C07C57/76Acyl halides containing halogen outside the carbonyl halide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1354451 Anorexigenic compositions BOEHRINGER INGELHEIM GmbH 30 April 1971 [2 May 1970] 12443/71 Heading A5B [Also in Division C2] Pharmaceutical compositions having good anorexigenic activity with only a slight central stimulating activity and low toxicity comprise halogen-substituted phenylalkylamine and their derivatives of the formula (I): wherein Cl represents a chlorine atom in the 4- or 6-position; R 1 , R 2 and R 3 , which may be the same or different, each represents a hydrogen atom or a methyl group; and R 4 represents a hydrogen atom, an alkyl group with 1 to 4 carbon atoms, or a benzyl or theophylline - (7) - ethyl group, the group -CH 2 -CH 2 -R 5 (wherein R 5 represents a carboxyl, alkoxycarbonyl, aminocarbonyl or cyano group), the group -CH 2 -CN, the group -(CH 2 ) m -R 6 or -C m H 2m-1 (C 6 H 5 )-R 6 (wherein m is 2, 3 or 4 and R 6 represents a halogen atom or a hydroxyl, amino or acylamino group), the group -C n H 2n -CO-R (wherein n is 1 or 2 and R represents an alkyl group with I to 4 carbon atoms or a phenyl group), or the group -CO-R 7 (wherein R 7 represents an alkoxy group with 1 to 4 carbon atoms, or an alkylthio or benzyloxy group or an alkyl group which may if desired be substituted by a halogen atom or a hydroxyl or amino group) and acid addition salts thereof in association with a pharmaceutical carrier or excipient, and if desired with other physiologically active ingredients, such as laxatives, in a form suitable for oral or rectal administration.
GB1244371A 1970-05-02 1971-04-30 Halogen-substituted phenyl-alkylamines and their derivatives Expired GB1354451A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2021620A DE2021620C3 (en) 1970-05-02 1970-05-02 New phenylaminoalkanes and processes for their preparation

Publications (1)

Publication Number Publication Date
GB1354451A true GB1354451A (en) 1974-06-05

Family

ID=5770113

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1244371A Expired GB1354451A (en) 1970-05-02 1971-04-30 Halogen-substituted phenyl-alkylamines and their derivatives

Country Status (22)

Country Link
JP (4) JPS5750773B1 (en)
AT (6) AT317172B (en)
BE (1) BE766654A (en)
BG (5) BG19589A3 (en)
CH (4) CH579023A5 (en)
CS (3) CS170545B2 (en)
DE (1) DE2021620C3 (en)
ES (4) ES390778A1 (en)
FI (1) FI53571C (en)
FR (1) FR2092123B1 (en)
GB (1) GB1354451A (en)
HU (1) HU162545B (en)
IE (1) IE35608B1 (en)
IL (1) IL36743A (en)
NL (1) NL169462C (en)
NO (1) NO133708C (en)
PL (3) PL90714B1 (en)
RO (5) RO57681A (en)
SE (1) SE374355B (en)
SU (2) SU439963A3 (en)
YU (6) YU35571B (en)
ZA (1) ZA712788B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2239012A1 (en) * 1972-08-08 1974-02-21 Knoll Ag BASIC SUBSTITUTED THEOPHYLLINE COMPOUNDS
JPS6016016U (en) * 1983-07-12 1985-02-02 本田技研工業株式会社 Positioning clip
EP0146067A3 (en) * 1983-12-06 1987-03-04 Merrell Dow Pharmaceuticals Inc. Novel substrates for d-amino acid oxidase
JPS6314015U (en) * 1986-07-11 1988-01-29
JPS63136497A (en) * 1986-11-28 1988-06-08 Hitachi Medical Corp X-ray device
JPH0378128U (en) * 1989-11-30 1991-08-07

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2029385A1 (en) * 1969-01-27 1970-10-23 Science Union & Cie

Also Published As

Publication number Publication date
FR2092123B1 (en) 1974-08-30
JPS5750773B1 (en) 1982-10-28
SE374355B (en) 1975-03-03
SU440825A3 (en) 1974-08-25
RO57681A (en) 1975-02-15
DE2021620B2 (en) 1979-06-13
IE35608B1 (en) 1976-03-31
CH570968A5 (en) 1975-12-31
ES402638A1 (en) 1975-11-01
DE2021620A1 (en) 1971-11-18
CS170545B2 (en) 1976-08-27
NL7105946A (en) 1971-11-04
BG19589A3 (en) 1975-06-25
NO133708C (en) 1976-06-16
AT317175B (en) 1974-08-12
CH561169A5 (en) 1975-04-30
NO133708B (en) 1976-03-08
YU36285B (en) 1982-06-18
JPS5655351A (en) 1981-05-15
BE766654A (en) 1971-11-03
CH579023A5 (en) 1976-08-31
CS175428B2 (en) 1977-05-31
CH579022A5 (en) 1976-08-31
PL90714B1 (en) 1977-01-31
BG19131A3 (en) 1975-04-30
JPS5655352A (en) 1981-05-15
PL85189B1 (en) 1976-04-30
RO62296A (en) 1978-01-15
ZA712788B (en) 1973-01-31
SU398031A3 (en) 1973-09-17
JPS5751822B2 (en) 1982-11-04
NL169462C (en) 1982-07-16
YU249878A (en) 1981-08-31
AT317172B (en) 1974-08-12
IL36743A0 (en) 1971-06-23
CS194665B2 (en) 1979-12-31
FR2092123A1 (en) 1972-01-21
PL91964B1 (en) 1977-03-31
YU249978A (en) 1981-08-31
JPS5725535B2 (en) 1982-05-29
IE35608L (en) 1971-11-02
RO57814A (en) 1975-06-15
HU162545B (en) 1973-03-28
YU36286B (en) 1982-06-18
BG18601A3 (en) 1975-02-25
DE2021620C3 (en) 1980-02-07
YU108071A (en) 1980-10-31
JPS5655350A (en) 1981-05-15
SU439963A3 (en) 1974-08-15
RO62418A (en) 1978-03-15
YU159080A (en) 1983-04-27
AT317174B (en) 1974-08-12
ES390778A1 (en) 1973-06-01
FI53571B (en) 1978-02-28
FI53571C (en) 1978-06-12
SU440824A3 (en) 1974-08-25
YU43381A (en) 1982-06-30
YU36482B (en) 1984-02-29
JPS589090B2 (en) 1983-02-18
AT317176B (en) 1974-08-12
NL169462B (en) 1982-02-16
AT317173B (en) 1974-08-12
ES402637A1 (en) 1975-12-16
BG21016A3 (en) 1976-01-20
AT317171B (en) 1974-08-12
YU35571B (en) 1981-04-30
BG21017A3 (en) 1976-01-20
IL36743A (en) 1974-12-31
RO57821A (en) 1975-06-15
YU37114B (en) 1984-08-31
YU250078A (en) 1982-02-25
ES402636A1 (en) 1976-01-01

Similar Documents

Publication Publication Date Title
KR970704435A (en) Use of Heterocyclic Compounds as Dopamine-D Ligands (Use of Heterocyclic Compounds as Dopamine-D Ligands)
KR920008026A (en) Isoquinolinone derivatives or nontoxic acid addition salts thereof or hydrates thereof, methods for preparing the same, and pharmaceutical compositions comprising the same
KR900004333A (en) Angiogenesis inhibitors
ES8603870A1 (en) Derivatives of 2,2'-iminobisethanol.
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
BG60102B2 (en) Method for preparing of 5-fluoro-2[[(4-cyclopropylmethoxy-2-pyridyl)methyl]thionyl]-1h-ben zimidazole
NO810478L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED IMIDAZOLD DERIVATIVES
KR890000470A (en) 2,2-dimethylchroman-3-ol derivative, preparation method thereof, and pharmaceutical composition containing same
DK0615754T3 (en) Solid flupertin-containing oral administration forms with controlled release of the active compound
NO824062L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLE DERIVATIVES.
GB1354451A (en) Halogen-substituted phenyl-alkylamines and their derivatives
FR2699176B1 (en) New bicyclic pyrimidine compounds, process for their preparation and pharmaceutical compositions containing them.
IT1191845B (en) PHARMACOLOGICALLY ACTIVE ALCHYLOLS
ATE18761T1 (en) CARBAMOYLOXYBENZHYDROL DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS.
DE3060888D1 (en) 5(10- 9)abeo-ergoline derivatives, their preparation, and therapeutic compositions containing them
GB1497729A (en) Benzenesulphonyl ureas and process for their manufacture
GB1174349A (en) Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
GB1451423A (en) 1-oxo-1h-6-substituted pyrimido-1,2-a-quinoline-2-carboxylic acids and derivatives thereof as antiallergy agents
ES8704460A1 (en) 2-Pyridine-thiol derivatives, processes for their preparation and pharmaceutical compositions containing them.
EP0325044A3 (en) Pharmacologically active cyclic peptide
KR880011163A (en) 4- benzyl- piperazinyl hydrazone
KR880009943A (en) Pyridazinone derivatives
GB1054278A (en) Pharmaceutical preparations having hypoglycaemic properties
FR2572074B1 (en) THIADIAZOLE DERIVATIVES ACTIVE IN THE CENTRAL NERVOUS SYSTEM, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
KR880001630A (en) 5-fluorouracil derivatives and uses thereof

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
SPA Amended specification published
PCNP Patent ceased through non-payment of renewal fee